• 1
    Tenenbein M: Good reasons to publish in Clinical Toxicology. J Toxicol Clin Toxicol 36:137138, 1998
  • 2
    Lavergne V, Nolin TD, Hoffman RS, Robert D, Gosselin S, Goldfarb DS, Kielstein JT, Mactier R, MacLaren R, Mowry JB, Bunchman TE, Juurlink D, Megarbane B, Anseeuw K, Winchester JF, Dargan PI, Liu KD, Hoegberg LC, Li Y, Calello D, Burdmann EA, Yates C, Laliberte M, Decker BS, Mello-Da-Silva CA, Lavonas E, Ghannoum M: The EXTRIP (Extracorporeal Treatments In Poisoning) workgroup: Guideline methodology. Clin Toxicol 50:403413, 2012
  • 3
    Schulz KF, Altman DG, Moher D, Group C: CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials. Ann Intern Med 152:726732, 2010
  • 4
    von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP, Initiative S: The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet 370:14531457, 2007
  • 5
    Moher D, Liberati A, Tetzlaff J, Altman DG, Group P: Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med 151:264269;W264, 2009
  • 6
    Bossuyt PM, Reitsma JB, Bruns DE, Gatsonis CA, Glasziou PP, Irwig LM, Lijmer JG, Moher D, Rennie D, de Vet HC: Standards for Reporting of Diagnostic A. Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. BMJ 326:4144, 2003
  • 7
    Husereau D, Drummond M, Petrou S, Carswell C, Moher D, Greenberg D, Augustovski F, Briggs AH, Mauskopf J, Loder E, Force CT: Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement. Clin Ther 35:356363, 2013
  • 8
    Kelly WN, Arellano FM, Barnes J, Bergman U, Edwards IR, Fernandez AM, Freedman SB, Goldsmith DI, Huang K, Jones JK, McLeay R, Moore N, Stather RH, Trenque T, Troutman WG, van Puijenbroek E, Williams F, Wise RP, International Society of P: Guidelines for submitting adverse event reports for publication. Pharmacoepidemiol Drug Saf 16:581587, 2007
  • 9
    Agbabiaka TB, Savović J, Harris R, Ernst E: The development of a tool to assess the quality of case reports of adverse events. Int J Risk Saf Med 10:123133, 2008
  • 10
    Gagnier JJ, Kienle G, Altman DG, Moher D, Sox H, Riley D; Group C: The CARE guidelines: consensus-based clinical case report guideline development. J Clin Epidemiol 67:4651, 2014
  • 11
    Ruha AM: The case report: a tool for the toxicologist. J Med Toxicol 5:12, 2009
  • 12
    Richason TP, Paulson SM, Lowenstein SR, Heard KJ: Case reports describing treatments in the emergency medicine literature: missing and misleading information. BMC Emerg Med 9:10, 2009
  • 13
    Drenth JP, Smits P, Thien T, Stalenhoef AF: The case for case reports in the Netherlands Journal of Medicine. Neth J Med 64:262264, 2006
  • 14
    Moher D, Schulz KF, Simera I, Altman DG: Guidance for developers of health research reporting guidelines. PLoS Med 7:e1000217, 2010
  • 15
    Landis JR, Koch GG: The measurement of observer agreement for categorical data. Biometrics 33:159174, 1977
  • 16
    Yang AW, Li CG, Da Costa C, Allan G, Reece J, Xue CC: Assessing quality of case series studies: development and validation of an instrument by herbal medicine CAM researchers. J Altern Complement Med 15:513522, 2009
  • 17
    Fitch K, Bernstein SJ, Aguilar MD, Burnand B, LaCalle JR, Lazaro P, Loo MVH, McDonnell J, Vader JP, Kahan JP: The RAND/UCLA Appropriateness Method User's Manual. Santa Monica, CA: RAND, 2011
  • 18
    Shrout PE, Fleiss JL: Intraclass correlations: uses in assessing rater reliability. Psychol Bull 86:420428, 1979
  • 19
    Henderson SO, Korn CS, Mallon WK: Excess case reports in the emergency medicine literature. Ann Emerg Med 34:805806, 1999